Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced an expansion of its Cue Integrated Care Platform to include a new pharmacy offering with over-the-counter and prescription...
Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its first quarter 2023 financial results on Wednesday, May 10, 2023. In conjunction with...
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cue Health Inc. (“Cue Health” or “the Company”) (NASDAQ:...
The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Cue Health Inc. (“Cue Health” or “the Company”) (NASDAQ:...
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced it has received Emergency Use Authorization (EUA) from the United States Food and Drug Administration (FDA) for its...
Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the fourth quarter and full-year 2022.
Cue Health (“Cue”) (Nasdaq: HLTH), a healthcare technology company, today announced the nationwide launch of a new suite of consumer-friendly, at-home diagnostic test kits. These easy-to-use kits provide...
Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology leader in at-home and point-of-care diagnostic innovations, today announced a new collaboration with Pfizer Inc. in the U.S. to raise awareness...
Cue Health Inc. (“Cue”) (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its fourth quarter and full-year 2022 financial results on Wednesday, March 15, 2023. In...
Cue Health (“Cue”) (Nasdaq: HLTH), the healthcare technology company known for diagnostic enabled care, announced today that its management team will participate at the following investor conferences:...